Randomised controlled trial of inhaled corticosteroids in patients with chronic obstructive pulmonary disease

Bourbeau, Jean; Rouleau, Michel Y.; Boucher, Serge
June 1998
Thorax;Jun1998, Vol. 53 Issue 6, p477
Academic Journal
No abstract available.


Related Articles

  • Therapeutics. Inhaled corticosteroids for people with chronic obstructive pulmonary disease are associated with an increased risk of fracture. Putcha, Nirupama; Drummond, M. Bradley // Evidence Based Medicine;Jun2012, Vol. 17 Issue 3, p90 

    The authors comment on the study "Risk of fractures with inhaled corticosteroids in COPD: systematic review and meta-analysis of randomised controlled trials and observational studies," by Y. K. Loke, R. Cavallazzi, and S. Singh, in the August 2011 issue of "Thorax." They note the relationship...

  • CHRONIC OBSTRUCTIVE PULMONARY DISEASE.  // Current Medical Literature: Respiratory Medicine;2005, Vol. 19 Issue 4, p86 

    Presents abstracts of several studies related to chronic obstructive pulmonary disease. "Barriers and Facilitators to End-of-Life Care Communication for Patients With COPD," by E. Knauft, E. L. Nielsen and R. A. Engelberg; "First Study of Infliximab Treatment in Patients With Chronic...

  • Inhaled corticosteroids help in chronic obstructive pulmonary disease. Marcovitch, Harvey // BMJ: British Medical Journal (International Edition);12/13/2003, Vol. 327 Issue 7428, p1369 

    Discusses a meta-analysis of eight randomised controlled trials which showed that inhaled corticosteroids reduced the annual rate of fall of forced expiratory volume in one second for patients with chronic obstructive pulmonary disease. Trials which lasted at least two years and involved 3715...

  • Inhaled corticosteroids worth it in patients with severe COPD.  // PharmacoEconomics & Outcomes News;5/8/2004, Issue 452, p9 

    Deals with the findings of a study regarding the use of inhaled corticosteroids among patients with chronic obstructive pulmonary disease. Cost effectiveness of inhaled corticosteroids; Mortality benefit of inhaled corticosteroids.

  • Budesonide/Formoterol: A Viewpoint by Paul W. Jones. Jones, Paul W. // Drugs;2004, Vol. 64 Issue 4, p444 

    Budesonide/formoterol is a fixed-dose combination of the corticosteroid budesonide and formoterol, a long-acting J32-agonist, inhaled as a dry powder. Current guidelines for chronic obstructive pulmonary disease (COPD) recommend a long-acting p2-agonist for patients whose symptoms are not...

  • Inhaled Steroids Increase Risk of TB in COPD Patients.  // Clinical Cardiology Alert;Jun2013 Clinical Briefs in Primary Care, p12 

    The article focuses on inhaled corticosteroids (ICS) were the use of these steroids leads to increase the risk of pulmonary tuberculosis (TB) in patients with chronic obstructive pulmonary disease (COPD).

  • Do Oral Corticosteroids Help Exacerbations of COPD? Walling, Anne D. // American Family Physician;11/15/1999, Vol. 60 Issue 8, p2415 

    Presents an abstract of the study `Oral Corticosteroids in Patients Admitted to Hospital With Exacerbations of Chronic Obstructive Pulmonary Disease: A Prospective Randomised Controlled Trial,' by L. Davis et al., which appeared on the August 7, 1999 issue of `The Lancet.'

  • Inhaled corticosteroids don't increase nonvertebral fracture risk.  // Reactions Weekly;1/29/2005, Issue 1036, p5 

    Presents the results of a study on the association between the use of inhaled corticosteroids and the risk of nonvertebral fractures in patients with chronic obstructive pulmonary disease in the U.S. Comparison between patients with a treated nonvertebral fracture and patients who served as the...

  • Inhaled corticosteroids and COPD exacerbations. Kuritzky, Louis // Primary Care Reports;Apr2010 Clinical Briefs, p8 

    The article discusses research being done on inhaled corticosteroids and chronic obstructive pulmonary disease (COPD), referencing the study "Inhaled Corticosteroids vs. Placebo for Preventing COPD Exacerbations: A Systematic Review and Metaregression of Randomized Controlled Trials," by R....

  • The INPULSIS enigma: exacerbations in idiopathic pulmonary fibrosis. Suissa, Samy; Ernst, Pierre // Thorax;May2015, Vol. 70 Issue 5, p508 

    The authors comment on randomized controlled trial conducted to study effectiveness of nintedanib drug in the treatment of idiopathic pulmonary fibrosis (IPF) in terms of declining lung function. Topics discussed include phenomenon of treatment effect dilution, increased risk of pneumonia with...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics